Skip navigation

Current DateTime: 11:10:46 05 Dec 2008
LinksList Documentid: 24890560
  • Predictions '09

      Find out what trends, events, people and forces are likely to shape the world of business in 2009.

  • Holiday Central

      Your one stop destination for all the latest retail news, blog reports, shopping tips and holiday slideshows.

  • Wall Street In Crisis

      With shock after shock to the world's financial system, the credit crunch continues to drive a major reconfiguration of the Wall Street landscape.

Japan Hot Stocks-Daiwa Sec, Komatsu, Banks, Orix, Doutor
By AFX | 05 Dec 2008 | 12:31 AM ET
Text Size

TOKYO, Dec 5 (Reuters) - The benchmark Nikkei average added 0.8 percent, while the broader TOPIX index rose 0.2 percent as of 0509 GMT on Friday. The following stocks were on the move: **DAIWA SEC JUMPS, GOLDMAN UPGRADES TO 'NEUTRAL'** Shares of Daiwa Securities Group Inc rose 7.9 percent to 462 yen after Goldman Sachs lifted its rating on Japan's second-largest brokerage to "neutral" from "sell", while setting a target price of 460 yen. Goldman said it believes Daiwa's stock has factored in harsh business conditions and predicted it would outperform rival Nomura Holdings. "We expect outperformance of peer Nomura Holdings, which harbors greater potential loss concerns in our view, including exposure to Icelandic financial institution credit derivatives," Goldman said in a note to clients. Goldman also noted the potential for Daiwa to book gains on the sale of its stake in Sanyo Electric, which is being targeted for a takeover by Panasonic Corp. 0510 GMT **KOMATSU DOWN AFTER ANNOUNCING OUTPUT CUTS** Komatsu Ltd, the world's second-biggest earth-moving equipment maker, lost 3.9 percent to 906 yen after the company said it would suspend operations of power shovel plants at home and abroad for two to four days per month from December. "The market for small-to-medium power shovels is tough, although demand for large mining equipment remains solid," said a Komatsu spokesman. . 0438 GMT **BANKS FALL ON FEARS ABOUT BANKRUPTCY BY U.S. AUTOMAKERS** Japanese bank shares slid on fears about the potential fallout if big U.S. automakers file for bankruptcy, market analysts said. Japan's top lender Mitsubishi UFJ Financial Group sank 5 percent to 437 yen, while No.2 Mizuho Financial Group lost 6.6 percent to 211,100 yen and Sumitomo Mitsui Financial Group, the third-ranked bank, shed 3.8 percent to 294,400 yen. "Concerns have spread that financial institutions including Japanese ones wouldn't be able escape unscathed if big U.S. automakers were to go bankrupt," said Tsuyoshi Segawa, an equity strategist at Shinko Securities. "We have no idea what could happen and where if a huge corporation like that failed." 0437 GMT **ORIX UP AFTER REQUESTS PROBE, SAYS FINANCES FINE** Shares of Orix Corp rose as much as 3.3 percent after saying it has asked Japan's securities regulator to investigate "untruthful information" that was circulating about the company and impacting its stock price. Orix, Japan's biggest leasing company and an active investor in the property market, also said it had secured a commitment line of 100 billion yen ($1.1 billion) from 30 financial institutions and there were no problems with its finances. The stock then trimmed gains, and was up 0.2 percent at 4,490 yen. 0410 GMT **DOUTOR NICHIRES JUMPS ON NOMURA REPORT** Doutor Nichires Holdings Co Ltd jumped 7.2 percent to 1,820 yen after Nomura Securities said the low-price coffee shop chain is less likely to suffer from the economic downturn than more upscale rivals like Starbucks Coffee Japan Ltd. The brokerage also said in a research note that a rise in milk prices is expected to hurt Starbucks more than Doutor given the former's higher sales proportion of cafe latte items, while the latter is likely to benefit from a sharp drop in coffee bean prices. Starbucks shares were flat at 38,000 yen. 0200 GMT **CHUGAI DOWN AS FDA SEEKS MORE DATA ON ACTEMRA** Chugai Pharmaceutical Co Ltd fell 10.7 percent to 1,430 yen after a further delay in U.S. approval for potential blockbuster rheumatoid arthritis drug Actemra, being developed by Chugai and its partner Roche Holding AG. The companies said on Thursday the Food and Drug Administration had requested additional animal data but had not ordered further clinical studies, and the two would submit the required information in the third quarter of next year. 0036 GMT **SHINOZAKIYA FACES SELLING GLUT AFTER CUTTING PROFIT FORECAST** Shinozakiya Inc was untraded with a glut of sellers at 4,800 yen, down 300 yen or 5.9 percent from Thursday's close of 5,100 yen, after Japan's only listed tofu maker nearly halved its annual profit forecast due to special losses related to a sale of its subsidiaries' shares. The company now expects a group net profit of 80 million yen ($867,400) for the business year to September 2009, instead of a previously projected 152 million yen profit. 0016 GMT (For IPO news, data and diary, click, for stocks click) (Reporting by Mariko Katsumura) ((mariko.katsumura@thomsonreuters.com; +81-3-6441-1811; Reuters Messaging: mariko.katsumura.reuters.com@reuters.net)) ($1=92.22 Yen) Keywords: MARKETS JAPAN STOCKS HOT =2 Keywords: MARKETS JAPAN STOCKS HOT =3 (Multimedia versions of Reuters Top News are now available for: * 3000 Xtra : visit http://topnews.session.rservices.com * BridgeStation: view story .134 * Reuters Plus: from your WebDSS screen For more information on Top News, visit http://topnews.reuters.com) COPYRIGHT Copyright Thomson Reuters 2008. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.


HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC MOBILE  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis